These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22199061)

  • 41. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
    Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical approaches for stable vitiligo.
    Falabella R
    Dermatol Surg; 2005 Oct; 31(10):1277-84. PubMed ID: 16188179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo.
    Khodadadi L; Shafieyan S; Sotoudeh M; Dizaj AV; Shahverdi A; Aghdami N; Baharvand H
    Arch Dermatol Res; 2010 Oct; 302(8):593-9. PubMed ID: 20364383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes.
    Falabella R; Escobar C; Borrero I
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):230-6. PubMed ID: 1552058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Procedural-Related Variables on Melanocyte-Keratinocyte Suspension Transplantation in Nonsegmental Stable Vitiligo: A Clinical and Immunocytochemical Study.
    El-Zawahry BM; Esmat S; Bassiouny D; Zaki NS; Sobhi R; Saleh MA; Abdel-Halim D; Hegazy R; Gawdat H; Samir N; El-Hawary M; El Maadawi Z; Gouda H; Khorshied M
    Dermatol Surg; 2017 Feb; 43(2):226-235. PubMed ID: 28157763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo.
    Machado Filho CD; Timoner FR
    An Bras Dermatol; 2014; 89(4):681-3. PubMed ID: 25054767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K; Parsad D; Kanwar AJ
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.
    Narayan VS; van den Bol LLC; van Geel N; Bekkenk MW; Luiten RM; Wolkerstorfer A
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1077-1086. PubMed ID: 33428279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acral vitiligo and lesions over joints treated with non-cultured epidermal cell suspension transplantation.
    Holla AP; Sahni K; Kumar R; Parsad D; Kanwar A; Mehta SD
    Clin Exp Dermatol; 2013 Jun; 38(4):332-7. PubMed ID: 23531153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanocyte-keratinocyte cell transplantation for stable vitiligo.
    Mulekar SV
    Int J Dermatol; 2003 Feb; 42(2):132-6. PubMed ID: 12709002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suction device for epidermal grafting in vitiligo: employing a syringe and a manometer to provide an adequate negative pressure.
    Kim HU; Yun SK
    Dermatol Surg; 2000 Jul; 26(7):702-4. PubMed ID: 10886287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of clinical efficacy and laboratory indicators of non-cultured epidermal cell suspension and hair follicle cell suspension in surgical management of stable vitiligo: A randomized comparative trial.
    Challa A; Chauhan S; Pangti R; Arava SK; Prajapati S; Pandey A; Gupta S
    J Cosmet Dermatol; 2022 Dec; 21(12):6958-6964. PubMed ID: 36152013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microneedling and 5-flurouracil can enhance the efficacy of non-cultured epidermal cell suspension transplantation for resistant acral vitiligo.
    Albalat W; Elsayed M; Salem A; Ehab R; Fawzy M
    Dermatol Ther; 2022 Oct; 35(10):e15768. PubMed ID: 36190004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients.
    Liu B; Chen HH; Liu ZH; Liang JF; Xue RJ; Chen PJ; Li CX; Liang XD; Deng J; Ye RX; Zhang XB; Liang JY
    J Dermatolog Treat; 2021 Feb; 32(1):90-94. PubMed ID: 31084382
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of platelet-rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double-blind randomized controlled trial.
    Parambath N; Sharma VK; Parihar AS; Sahni K; Gupta S
    Int J Dermatol; 2019 Apr; 58(4):472-476. PubMed ID: 30506679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo.
    Vashisht KR; Arava SK; Tembhre MK; Parihar AS; Sharma VK; Das BK; Sreenivas V; Sethuraman G; Gupta S
    Clin Exp Dermatol; 2020 Mar; 45(2):172-179. PubMed ID: 31361909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.